Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 65-71 , January 2007

Short term efficacy of a lifestyle intervention programme on cardiovascular health outcome in overweight Indigenous Australians with and without type 2 diabetes mellitus: The healthy lifestyle programme (HELP)

  • Lionel C.K. Chan

      Affiliations

    • Discipline of Medicine, The University of Queensland, The Prince Charles Hospital, Chermside, Qld 4032, Australia
    • Corresponding Author InformationCorresponding author at: Discipline of Medicine, The University of Queensland, Clinical Sciences Building, The Prince Charles Hospital, Chermside, Qld 4032, Australia. Tel.: +61 7 3350 8801; fax: +61 7 3350 8654.
    • ,
  • Robert Ware

      Affiliations

    • School of Population Health, The University of Queensland, Brisbane, Qld 4006, Australia
    • ,
  • Janine Kesting

      Affiliations

    • Discipline of Medicine, The University of Queensland, The Prince Charles Hospital, Chermside, Qld 4032, Australia
    • ,
  • Maureen Marczak

      Affiliations

    • Discipline of Medicine, The University of Queensland, The Prince Charles Hospital, Chermside, Qld 4032, Australia
    • ,
  • David Good

      Affiliations

    • Discipline of Medicine, The University of Queensland, The Prince Charles Hospital, Chermside, Qld 4032, Australia
    • ,
  • Joanne T.E. Shaw

      Affiliations

    • Discipline of Medicine, The University of Queensland, The Prince Charles Hospital, Chermside, Qld 4032, Australia

Received 1 March 2006 ,Accepted 24 April 2006.

References 

  1. O’Dea K. Westernisation, insulin resistance and diabetes in Australian aborigines. Med. J. Aust. 1991;155:258–264
  2. Thompson PL, Bradshaw PJ, Veroni M, Wilkes ET. Cardiovascular risk among urban Aboriginal people. Med. J. Aust. 2003;179:143–146
  3. Australian Bureau of Statistics: 4715.0 National Health Survey: Aboriginal and Torres Strait Islander Results. Canberra, ABS, 2002.
  4. UK Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes UKPDS 38. BMJ. 1998;317:703–713
  5. UK Prospective Diabetes Study Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33. Lancet. 1998;352:837–853
  6. Stamler J, Vaccaro O, Neaton J, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabet. Care. 1993;16:434–444
  7. Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high risk individuals: a randomized placebo controlled trial. Lancet. 2002;360:7–22
  8. Pyorala K, Pederson TR, Kjekhus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabet. Care. 1997;20:614–620
  9. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J. Cardiovasc. Risk. 1998;5:229–232
  10. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 2000;160:1093–1100
  11. Hubert HB, Feinleib M, McNamara DM. Obesity is an independent risk factor for cardiovascular disease: a 26 year follow up of participants in the Framingham Heart study. Circulation. 1983;67:968–977
  12. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 2003;348:383–393
  13. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952
  14. Simons LA, Simons J, McCallum J, Friedlander Y. Impact of smoking, diabetes and hypertension on survival time in the elderly: The Dubbo Study. Med. J. Aust. 2005;182:219–222
  15. Currie CJ, Morgan CL, Dixon S, McEwan P, Marchant N, Bearne A, et al. The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications. Diabet. Res. Clin. Pract. 2005;67:144–151
  16. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?. Med. J. Aust. 2005;182:66–69
  17. Rowley K, Daniel M, Skinner K. Effectiveness of a community directed healthy lifestyle programme in a remote Australian Aboriginal community. Aust. N. Z. J. Pub. Health. 2000;24:136–144
  18. O’Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984;33:596–603
  19. Alberti KGMM, Aschner P, Assal J-P, Bennett PH, Groop L, Jervell J, et al. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications—Report of a WHO consultation. Geneva: World Health Organization; 1999;pp. 1–59
  20. World Health Organization, Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, WHO, 1998.
  21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  22. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabet. Care. 2003;26:2426–2432
  23. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus: United Kingdom prospective diabetes study UKPDS 23. BMJ. 1998;316:823–828
  24. The Practical Implementation Taskforce for the Prevention of Cardiovascular Disease . Prevention of cardiovascular disease: an evidence-based clinical aid. Med. J. Aust. 2004;18:F1–F14
  25. Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML. Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. Aust. N. Z. J. Med. 1996;26:519–525
  26. Gall M-A, Borch-Hohnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM (non-insulin-dependent diabetes mellitus). Diabetes. 1995;44:1303–1309
  27. Wiltshire S, Frayling TM, Groves CJ, Levy JC, Hitman GA, Sampson M, et al. Evidence from a large U.K. family collection that genes influencing age of onset of type 2 diabetes map to chromosome 12p and to the MODY3/NIDDM2 locus on 12q24. Diabetes. 2004;53:855–860
  28. ALLHAT Group . Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997
  29. Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med. J. Aust. 2003;179:580–585
  30. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–774

PII: S0168-8227(06)00168-9

doi: 10.1016/j.diabres.2006.04.012

Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 65-71 , January 2007

Article Tools